Wajid Ali sold $3.7M of LITE
EVP & CHIEF FINANCIAL OFFICER at Lumentum Holdings Inc.. 5,302 shares at an average of $691.13, traded Feb 27, 2026, filed Mar 2, 2026.
Score components
- +22RoleCFO
- +25Trade size$3.7M at market
- 0Share of holdings soldSold 7.4% of holdings
- +15Cluster3 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -2.4%, 3m +15.5%, 6m +16.8%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001561100-26-000002, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 27, 2026 | SOpen-market sale Common Stock10b5-1 | -200 | $677.78 | $136k | 71,389 | Mar 2, 2026 |
| Feb 27, 2026 | SOpen-market sale Common Stock10b5-1 | -424 | $679.95 | $288k | 70,965 | Mar 2, 2026 |
| Feb 27, 2026 | SOpen-market sale Common Stock10b5-1 | -500 | $681.48 | $341k | 70,465 | Mar 2, 2026 |
| Feb 27, 2026 | SOpen-market sale Common Stock10b5-1 | -200 | $685.50 | $137k | 70,265 | Mar 2, 2026 |
| Feb 27, 2026 | SOpen-market sale Common Stock10b5-1 | -160 | $686.54 | $110k | 70,105 | Mar 2, 2026 |
| Feb 27, 2026 | SOpen-market sale Common Stock10b5-1 | -475 | $688.42 | $327k | 69,630 | Mar 2, 2026 |
| Feb 27, 2026 | SOpen-market sale Common Stock10b5-1 | -155 | $690.13 | $107k | 69,475 | Mar 2, 2026 |
| Feb 27, 2026 | SOpen-market sale Common Stock10b5-1 | -731 | $692.02 | $506k | 68,744 | Mar 2, 2026 |
| Feb 27, 2026 | SOpen-market sale Common Stock10b5-1 | -450 | $694.76 | $313k | 68,294 | Mar 2, 2026 |
| Feb 27, 2026 | SOpen-market sale Common Stock10b5-1 | -355 | $696.12 | $247k | 67,939 | Mar 2, 2026 |
| Feb 27, 2026 | SOpen-market sale Common Stock10b5-1 | -300 | $697.08 | $209k | 67,639 | Mar 2, 2026 |
| Feb 27, 2026 | SOpen-market sale Common Stock10b5-1 | -1,108 | $698.10 | $773k | 66,531 | Mar 2, 2026 |
| Feb 27, 2026 | SOpen-market sale Common Stock10b5-1 | -244 | $699.28 | $171k | 66,287 | Mar 2, 2026 |
Related signals
Other insiders at Lumentum Holdings Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 40Moderate | Lumentum Holdings Inc. | Wajid Ali EVP & CHIEF FINANCIAL OFFICER | $26M 24,542 shares | -25% | |
| 30Weak | Lumentum Holdings Inc. | Yuen Wupen PRESIDENT, GLOBAL BUS. UNITS | $764k 807 shares | -1% | |
| 32Weak | Lumentum Holdings Inc. | Yuen Wupen PRESIDENT, GLOBAL BUS. UNITS | $928k 1,000 shares | -1% | |
| 33Weak | Lumentum Holdings Inc. | Yuen Wupen PRESIDENT, GLOBAL BUS. UNITS | $1.4M 1,500 shares | -1% | |
| 25Weak | Lumentum Holdings Inc. | Yuen Wupen PRESIDENT, GLOBAL BUS. UNITS | $1.4M 1,500 shares | -1% | |
| 25Weak | Lumentum Holdings Inc. | Yuen Wupen PRESIDENT, GLOBAL BUS. UNITS | $1.3M 1,500 shares | -1% | |
| 40Moderate | Lumentum Holdings Inc. | Yuen Wupen PRESIDENT, GLOBAL BUS. UNITS | $1.4M 1,500 shares | -1% | |
| 40Moderate | Lumentum Holdings Inc. | Yuen Wupen PRESIDENT, GLOBAL BUS. UNITS | $1.3M 1,500 shares | -1% | |
| 40Moderate | Lumentum Holdings Inc. | Yuen Wupen PRESIDENT, GLOBAL BUS. UNITS | $1.4M 1,500 shares | -1% | |
| 38Weak | Lumentum Holdings Inc. | Michael E. Hurlston President and CEO | $525k 548 shares | -0% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.